Lodoxamide is an ophthalmic agent used for the treatment of the ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis. Lodoxamide is a mast-cell stabilizer for topical administration into the eye.
- Mechanism
- Curator reviewed
Although lodoxamide's precise mechanism of action is unknown, it is postulated that it prevents calcium influx into mast cells upon antigen stimulation and therefore stabilizes the membrane. By stabilizing the mast cell membrane from degranulation, lodoxamide consequently inhibits the release of intracellular histamine and other chemoattractant factors that primarily cause ocular symptoms. Lodoxamide's mechanism of action may be similar to cromolyn sodium, as both exhibit cross-tachyphylaxis.
- Primary indication
- Indicated in the treatment of the ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.Curator reviewed · 5 structured indications
- Formula / weight
- C11H6ClN3O6 · 311.63 g/mol (avg)
- First approval
- Canada, 2017 · United States, 1993
- Code names
- U-42585E
- Brand names
Resolves to
RVGLGHVJXCETIO-UHFFFAOYSA-NSMILESOC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#NWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Lodoxamide, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account